Results 31 to 40 of about 160,800 (350)

MACULAR DEGENERATION [PDF]

open access: yesThe Journal OF Nervous and Mental Disease, 1920
n ...
openaire   +1 more source

Distinguishing wet from dry age-related macular degeneration using three-dimensional computer-automated threshold Amsler grid testing [PDF]

open access: yes, 2011
Background/aims: With the increased efficacy of current therapy for wet age-related macular degeneration (AMD), better ways to detect wet AMD are needed.
Bababeygy, Simon R.   +5 more
core   +1 more source

The Association Between Consumption of 100% Fruit Juice and Risk of Age-Related Macular Degeneration: Data From the National Health and Nutrition Examination Survey Database

open access: yesFrontiers in Nutrition, 2022
Age-related macular degeneration (AMD) is the main irreversible blindness disease worldwide. The current study aimed to investigate whether the consumption of 100% fruit juice increases the risk of age-related macular degeneration and find approaches to ...
Mi Song   +3 more
doaj   +1 more source

Dietary fatty acids and lipoproteins on progression of age-related macular degeneration [PDF]

open access: yes, 2017
Age-related macular degeneration (AMD) is a medical condition of central loss vision and blindness. Numerous studies have revealed that changes on certain dietary fatty acids (FAs) could have useful for AMD management.
Abia González, María del Rocío   +5 more
core   +3 more sources

The role of oxidative stress and antioxidants in the pathogenesis of age-related macular degeneration

open access: yesClinics, 2011
OBJECTIVE: To investigate the role of oxidant/antioxidant status and protein oxidation in the development of age-related macular degeneration. METHOD: The activities of serum superoxide dismutase and glutathione peroxidase and the levels of serum ...
Zuhal Yildirim   +2 more
doaj   +1 more source

Extracellular vesicles as a potential therapeutic for age-related macular degeneration

open access: yesNeural Regeneration Research, 2023
Age-related macular degeneration is a major global cause of central visual impairment and severe vision loss. With an aging population, the already immense economic burden of costly anti-vascular endothelial growth factor treatment is likely to increase.
Lorraine L. C. Chow, Ben Mead
doaj   +1 more source

Morphologic Criteria of Lesion Activity in Neovascular Age-Related Macular Degeneration: A Consensus Article [PDF]

open access: yes, 2017
Intravitreal antivascular endothelial growth factor drugs represent the current standard of care for neovascular age-related macular degeneration (nAMD).
Elena Gusson   +8 more
core   +1 more source

Treatment Methods Dry Form of Age Macular Degeneration — History and Prospects. Review

open access: yesOftalʹmologiâ, 2023
Age related macular degeneration is a leading cause of vision loss and an increasing problem of disability throughout the world among adults. That revue covers historical points, risk factors, pathogenesis, classification and current treatment ways of ...
A. N. Kulikov   +2 more
doaj   +1 more source

Cost effectiveness of photodynamic therapy with verteporfin for age related macular degeneration: the UK case [PDF]

open access: yes, 2004
AIM: To estimate the potential cost effectiveness of photodynamic therapy (PDT) with verteporfin in the UK setting. METHODS: Using data from a variety of sources a Markov model was built to produce estimates of the cost effectiveness (incremental cost ...
Drummond, M., Fenn, P., Smith, D.H.
core   +2 more sources

New Frontiers in Retina: highlights of the 2020 angiogenesis, exudation and degeneration symposium

open access: yesInternational Journal of Retina and Vitreous, 2020
We summarize the most important findings presented at the 2020 angiogenesis, exudation and degeneration symposium in five topic areas: (1) epidemiology of retinal vascular disease and macular degeneration; (2) dry AMD and geographic atrophy; (3 ...
Carmen A. Puliafito, Charles C. Wykoff
doaj   +1 more source

Home - About - Disclaimer - Privacy